|
|
|
CML Medical Journal Articles
Home
Gleevec
Resource Center
Back to CML Medical Journal
Articles
| Journal Articles About CML |
|
CLINICAL CANCER RESEARCH
Imatinib therapy for
patients with chronic myelogenous leukemia: Are patients living
longer
Jan. 1, 2004
Pharmacogenomic
analysis of cytogenetic response in chronic myeloid leukemia
patients treated with imatinib
Jan. 1, 2004
Survival advantage
with imatinib mesylate therapy in chronic-phase chronic myelogenous
leukema (CML-CP) after interferon-alpha failure and in late CML-CP,
comparison with historical controls
Jan. 1, 2004
The effect of
imatinib mesylate on patients with Philadelphia-chromosome positive
chronic myeloid leukemia with secondary chromosomal aberrations
Clinical Cancer Research, Vol. 9, 1333-1337, April 2003
Understanding the
molecular basis of imatinib mesylate therapy in chronic myelogenous
leukemia and the related mechanisms of resistance
Clinical Cancer Research, Vol. 9, 1248-1252, April 2003
Treatment
of Philadelphia Chromosome-positive, Accelerated-phase Chronic
Myelogenous Leukemia with Imatinib Mesylate
Clinical Cancer Research, Vol. 8, 2167–2176, July 2002
|
|
Give me a holler
Today Is:
© 2000-2004 CMLSupport.com Inc. All rights reserved.
These contents may not be reproduced in whole or in part in any medium
without the express written permission of CMLSupport.com Inc. This site is
best viewed with Internet Explorer.
|
|